Cargando…

Therapeutic Action of the Mitochondria-Targeted Antioxidant SkQ1 on Retinopathy in OXYS Rats Linked with Improvement of VEGF and PEDF Gene Expression

The incidence of age-related macular degeneration (AMD), the main cause of blindness in older patients in the developed countries, is increasing with the ageing population. At present there is no effective treatment for the prevailing geographic atrophy, dry AMD, whereas antiangiogenic therapies suc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markovets, Anton M., Fursova, Anzhella Z., Kolosova, Natalia G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130050/ https://www.ncbi.nlm.nih.gov/pubmed/21750722 http://dx.doi.org/10.1371/journal.pone.0021682

Ejemplares similares

The Mitochondria-Targeted Antioxidant SkQ1 Downregulates Aryl Hydrocarbon Receptor-Dependent Genes in the Retina of OXYS Rats with AMD-Like Retinopathy
por: Perepechaeva, M. L., et al.
Publicado: (2014)

Suppression of AMD-Like Pathology by Mitochondria-Targeted Antioxidant SkQ1 Is Associated with a Decrease in the Accumulation of Amyloid β and in mTOR Activity
por: Muraleva, Natalia A., et al.
Publicado: (2019)

Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents
por: Anisimov, Vladimir N., et al.
Publicado: (2011)

The mitochondria-targeted antioxidant SkQ1 but not N-acetylcysteine reverses aging-related biomarkers in rats
por: Kolosova, Nataliya G., et al.
Publicado: (2012)

Mitochondria-targeted antioxidant SkQ1 reduces age-related alterations in the ultrastructure of the lacrimal gland
por: Bakeeva, Lora E., et al.
Publicado: (2016)

The Analgesic Effect of the Mitochondria-Targeted Antioxidant SkQ1 in Pancreatic Inflammation
por: Weniger, Maximilian, et al.
Publicado: (2016)

Mitochondria-targeted antioxidant SkQ1 inhibits leukotriene synthesis in human neutrophils
por: Sud’ina, Galina F., et al.
Publicado: (2022)

Mitochondria-targeted antioxidant SkQ1 inhibits age-dependent involution of the thymus in normal and senescence-prone rats
por: Obukhova, Lidia A., et al.
Publicado: (2009)

Alterations of retinal pigment epithelium cause AMD-like retinopathy in senescence-accelerated OXYS rats
por: Markovets, Anton M., et al.
Publicado: (2010)

Antioxidant SkQ1 delays sarcopenia-associated damage of mitochondrial ultrastructure
por: Vays, Valeriya B., et al.
Publicado: (2014)

Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study
por: Stefanova, Natalia A., et al.
Publicado: (2019)

Mitochondria-Targeted Antioxidant SkQ1 Prevents Anesthesia-Induced Dry Eye Syndrome
por: Zernii, Evgeni Yu., et al.
Publicado: (2017)

Therapeutic Effect of the Mitochondria-Targeted Antioxidant SkQ1 on the Culture Model of Multiple Sclerosis
por: Fetisova, Elena K., et al.
Publicado: (2019)

Mitochondria-targeted antioxidant SkQ1 improves impaired dermal wound healing in old mice
por: Demyanenko, Ilya A., et al.
Publicado: (2015)

Mitochondria-Targeted Antioxidant SkQ1 Improves Dermal Wound Healing in Genetically Diabetic Mice
por: Demyanenko, Ilya A., et al.
Publicado: (2017)

Mitochondrial antioxidant SkQ1 decreases inflammation following hemorrhagic shock by protecting myocardial mitochondria
por: Jia, Bo, et al.
Publicado: (2022)

Changes in Glial Support of the Hippocampus during the Development of an Alzheimer’s Disease-like Pathology and Their Correction by Mitochondria-Targeted Antioxidant SkQ1
por: Rudnitskaya, Ekaterina A., et al.
Publicado: (2022)

SkQ1 Suppresses the p38 MAPK Signaling Pathway Involved in Alzheimer’s Disease-Like Pathology in OXYS Rats
por: Muraleva, Natalia A., et al.
Publicado: (2020)

Mitochondria-Targeted Antioxidant SkQ1 Prevents the Development of Experimental Colitis in Mice and Impairment of the Barrier Function of the Intestinal Epithelium
por: Fedorov, Artem V., et al.
Publicado: (2022)

Efficacy of Mitochondrial Antioxidant Plastoquinonyl-decyl-triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune Arthritis
por: Andreev-Andrievskiy, Alexander A., et al.
Publicado: (2016)

Treating Neurodegenerative Disease with Antioxidants: Efficacy of the Bioactive Phenol Resveratrol and Mitochondrial-Targeted MitoQ and SkQ
por: Shinn, Lindsey J., et al.
Publicado: (2021)

Mitochondria-Targeted Antioxidants SkQ1 and MitoTEMPO Failed to Exert a Long-Term Beneficial Effect in Murine Polymicrobial Sepsis
por: Rademann, Pia, et al.
Publicado: (2017)

Mitochondrion-targeted antioxidant SkQ1 prevents rapid animal death caused by highly diverse shocks
por: Skulachev, V. P., et al.
Publicado: (2023)

Improved health-span and lifespan in mtDNA mutator mice treated with the mitochondrially targeted antioxidant SkQ1
por: Shabalina, Irina G., et al.
Publicado: (2017)

SkQ1 treatment and food restriction — two ways to retard an aging program of organisms
por: Skulachev, Vladimir P.
Publicado: (2011)

Mitochondrial Antioxidant SkQ1 Has a Beneficial Effect in Experimental Diabetes as Based on the Analysis of Expression of microRNAs and mRNAs for the Oxidative Metabolism Regulators
por: Dvoretskaya, Yuliya, et al.
Publicado: (2021)

Genetic Variability of the AcrAB-TolC Multidrug Efflux Pump Underlies SkQ1 Resistance in Gram-Negative Bacteria
por: Nazarov, P. A., et al.
Publicado: (2019)

SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model
por: Petrov, Anton, et al.
Publicado: (2016)

Mitochondria-targeted antioxidant SKQ1 protects cornea from oxidative damage induced by ultraviolet irradiation and mechanical injury
por: Zernii, Evgeni Yu., et al.
Publicado: (2018)

Association between Polymorphisms in CFH, ARMS2, CFI, and C3 Genes and Response to Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration
por: Kozhevnikova, Oyuna S., et al.
Publicado: (2022)

PEDF in Diabetic Retinopathy: A Protective Effect of Oxidative Stress
por: Zhu, Xiao-feng, et al.
Publicado: (2012)

Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy
por: Chrząszcz, Michał, et al.
Publicado: (2021)

Pharmacogenetic Association between Allelic Variants of the Autophagy-Related Genes and Anti-Vascular Endothelial Growth Factor Treatment Response in Neovascular Age-Related Macular Degeneration
por: Kozhevnikova, Oyuna S., et al.
Publicado: (2023)

Mitochondrial Targeted Antioxidant SKQ1 Ameliorates Acute Kidney Injury by Inhibiting Ferroptosis
por: Song, Jiayu, et al.
Publicado: (2022)

Evaluation of VEGF and PEDF in prostate cancer: A preliminary study in serum and biopsies
por: Rivera-Pérez, Josué, et al.
Publicado: (2018)

The Role of SKQ1 (Visomitin) in Inflammation and Wound Healing of the Ocular Surface
por: Wei, Yi, et al.
Publicado: (2018)

The Yin and Yang of VEGF and PEDF: Multifaceted Neurotrophic Factors and Their Potential in the Treatment of Parkinson’s Disease
por: Falk, Torsten, et al.
Publicado: (2010)

Enhanced therapeutic effect of PEDF-loaded mesenchymal stem cell-derived small extracellular vesicles against oxygen-induced retinopathy through increased stability and penetrability of PEDF
por: Fan, Ruiyan, et al.
Publicado: (2023)

Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy
por: Matsuyama, Kayako, et al.
Publicado: (2008)

Long-Term Retinal PEDF Overexpression Prevents Neovascularization in a Murine Adult Model of Retinopathy
por: Haurigot, Virginia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jok6ce8amia8op795qj7fn2g3n